Dr. Ian Flinn, chief scientific officer at Tennessee Oncology and One Oncology in Nashville, Tennessee, explains Lunsumio ...

The U.S. Food and Drug Administration (FDA) approved six new therapies in December 2025 for blood cancers, prostate cancer, ...

Follicular lymphoma is a cancer of the B-cells that accounts for around one third of all cases of lymphoma. The cancer is a form of non-Hodgkin lymphoma that usually affects adults, with an average ...

RYE BROOK, N.Y., Aug. 7, 2024 /PRNewswire/ -- The Follicular Lymphoma Foundation (FLF), The Leukemia & Lymphoma Society (LLS) and the Institute for Follicular Lymphoma Innovation (IFLI), through their ...

AROUND 1,900 people are diagnosed with follicular lymphoma every year in the UK, but fortunately, there are ways of managing the disease. Nicola Mendelsohn, the 46-year-old Facebook boss, was ...

Follicular lymphoma is a type of non-Hodgkin lymphoma that involves abnormal growth of the B-lymphocytes (B-cells). The lymphocytes with abnormal cell growth can travel around the body and form tumors ...

Copanlisib, a drug that has recently been FDA approved for the treatment of follicular cancer, appears to be a good option to prevent relapses. Copanlisib has received accelerated approval by the US ...